Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference68 articles.
1. Faithfull, S., Lemanska, A., & Chen, T. (2015). Patient-reported outcome measures in radiotherapy: Clinical advances and research opportunities in measurement for survivorship. Clinical Oncology, 27(11), 679–685.
2. Cancer Research UK. (2012). Prostate cancer survival statistics. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/survival . Accessed September 09, 2016.
3. Widmark, A., Klepp, O., Solberg, A., Damber, J., Angelsen, A., Fransson, P., et al. (2009). Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial. Lancet, 373(9660), 301–308.
4. Horwitz, E. M., Bae, K., Hanks, G. E., Porter, A., Grignon, D. J., Brereton, H. D., et al. (2008). Ten-year follow-up of radiation therapy oncology group protocol 92–02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. Journal of Clinical Oncology, 26(15), 2497–2504.
5. Ray, M. E., Bae, K., Hussain, M. H., Hanks, G. E., Shipley, W. U., & Sandler, H. M. (2009). Potential surrogate endpoints for prostate cancer survival: Analysis of a phase III randomized trial. Journal of the National Cancer Institute, 101(4), 228–236.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献